{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:08:45Z","timestamp":1788566925059,"version":"build-2803163510"},"reference-count":71,"publisher":"American Association for Cancer Research (AACR)","issue":"5","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Bilateral salpingo-oophorectomy (BSO) has become the standard-of-care for risk reduction in women at hereditary risk of ovarian cancer. Although this procedure significantly decreases both the incidence of and mortality from ovarian cancer, it affects quality of life, and the premature cessation of ovarian function may have long-term health hazards. Recent advances in our understanding of the molecular pathways of ovarian cancer point to the fallopian tube epithelium as the origin of most high-grade serous cancers (HGSC). This evolving appreciation of the role of the fallopian tube in HGSC has led to the consideration of salpingectomy alone as an option for risk management, especially in premenopausal women. In addition, it is postulated that bilateral salpingectomy with ovarian retention (BSOR), may have a public health benefit for women undergoing benign gynecologic surgery. In this review, we provide the rationale for salpingectomy as an ovarian cancer risk reduction strategy. Cancer Prev Res; 8(5); 342\u20138. \u00a92015 AACR.<\/jats:p>\n               <jats:p>See related commentary by Mark H. Greene, p. 339<\/jats:p>","DOI":"10.1158\/1940-6207.capr-14-0293","type":"journal-article","created":{"date-parts":[[2015,1,14]],"date-time":"2015-01-14T06:53:55Z","timestamp":1421218435000},"page":"342-348","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Salpingectomy as a Means to Reduce Ovarian Cancer Risk"],"prefix":"10.1158","volume":"8","author":[{"given":"Mary B.","family":"Daly","sequence":"first","affiliation":[{"name":"1Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles W.","family":"Dresher","sequence":"additional","affiliation":[{"name":"2Department of Translational Outcomes Research Group of the Translational Research Program of the Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda S.","family":"Yates","sequence":"additional","affiliation":[{"name":"3Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M.","family":"Jeter","sequence":"additional","affiliation":[{"name":"4Department of Medicine, University of Arizona, Tucson, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth Y.","family":"Karlan","sequence":"additional","affiliation":[{"name":"5Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Alberts","sequence":"additional","affiliation":[{"name":"6University of Arizona Cancer Center, Tucson, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H.","family":"Lu","sequence":"additional","affiliation":[{"name":"3Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2015,4,30]]},"reference":[{"key":"2022060816275180400_bib1","first-page":"609","article-title":"Ovarian cancer: an overview","volume":"80","author":"Roett","year":"2009","journal-title":"Am Fam Physician"},{"key":"2022060816275180400_bib2","article-title":"Cancer incidence in five continents","author":"Parkin","year":"2005"},{"key":"2022060816275180400_bib3","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"2022060816275180400_bib4","first-page":"1","article-title":"Epidemiology of gynecologic cancers","author":"Brinton","year":"2013","edition":"6th ed"},{"key":"2022060816275180400_bib5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/sj.bjc.6603725","article-title":"No efficacy of annual gynaecological screening in BRCA1\/2 mutation carriers; an observational follow-up study","volume":"96","author":"Hermsen","year":"2007","journal-title":"Br J Cancer"},{"key":"2022060816275180400_bib6","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1200\/JCO.2005.05.097","article-title":"Screening for familial ovarian cancer: Failure of current protocols to detect ovarian cancer at an early stage according to the International Federation of Gynecology and Obstetrics System","volume":"23","author":"Stirling","year":"2005","journal-title":"J Clin Oncol"},{"key":"2022060816275180400_bib7","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/ijc.24038","article-title":"Time to stop ovarian cancer screening in BRCA1\/2 mutation carriers?","volume":"124","author":"van der Velde","year":"2009","journal-title":"Int J Cancer"},{"key":"2022060816275180400_bib8","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ajog.2005.05.005","article-title":"Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial","volume":"193","author":"Buys","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"2022060816275180400_bib9","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0b013e3181a106d4","article-title":"ACoGSoG. Hereditary breast and ovarian cancer. ACOG Practice Bulletin No. 103","volume":"113","author":"ACOG ACoOaG, Gynecology ACoPB, Oncologists","year":"2009","journal-title":"Obstet Gynecol"},{"key":"2022060816275180400_bib10","article-title":"Screening for Ovarian Cancer Clinical Summary of U.S. Preventive Services Task Force Recommendation;","author":"Force USPST","year":"2014"},{"key":"2022060816275180400_bib11","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"key":"2022060816275180400_bib12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/1097-0142(19950715)76:2<284::AID-CNCR2820760219>3.0.CO;2-5","article-title":"A prospective study of reproductive factors and risk of epithelial ovarian cancer","volume":"76","author":"Hankinson","year":"1995","journal-title":"Cancer"},{"key":"2022060816275180400_bib13","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/bjc.2011.371","article-title":"Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition","volume":"105","author":"Tsilidis","year":"2011","journal-title":"Br J Cancer"},{"key":"2022060816275180400_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/aje\/155.3.217","article-title":"Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies","volume":"155","author":"Ness","year":"2002","journal-title":"Am J Epidemiol"},{"key":"2022060816275180400_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.fertnstert.2004.02.109","article-title":"Ovarian cancer risk associated with varying causes of infertility","volume":"82","author":"Brinton","year":"2004","journal-title":"Fertil Steril"},{"key":"2022060816275180400_bib16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1472-6483(10)60175-7","article-title":"Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review","volume":"19","author":"Chittenden","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"2022060816275180400_bib17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ygyno.2007.12.003","article-title":"Hormone replacement therapy and ovarian cancer risk: a meta-analysis","volume":"108","author":"Zhou","year":"2008","journal-title":"Gynecol Oncol"},{"key":"2022060816275180400_bib18","first-page":"472","article-title":"Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis","volume":"92","author":"Garg","year":"1998","journal-title":"Obstet Gynecol"},{"key":"2022060816275180400_bib19","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"2022060816275180400_bib20","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/oxfordjournals.aje.a116429","article-title":"Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer","volume":"136","author":"Whittemore","year":"1992","journal-title":"Am J Epidemiol"},{"key":"2022060816275180400_bib21","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.ejca.2010.04.018","article-title":"Oral contraceptive use and breast or ovarian cancer risk in BRCA1\/2 carriers: a meta-analysis","volume":"46","author":"Iodice","year":"2010","journal-title":"Eur J Cancer"},{"key":"2022060816275180400_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/humupd\/dmq030","article-title":"Tubal ligation and the risk of ovarian cancer: review and meta-analysis","volume":"17","author":"Cibula","year":"2011","journal-title":"Hum Reprod Update"},{"key":"2022060816275180400_bib23","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1158\/1055-9965.EPI-08-0546","article-title":"Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1\/2 Carrier Cohort Study","volume":"18","author":"Antoniou","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060816275180400_bib24","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(00)04642-0","article-title":"Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","volume":"357","author":"Narod","year":"2001","journal-title":"Lancet"},{"key":"2022060816275180400_bib25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"2022060816275180400_bib26","first-page":"5329","article-title":"BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study","volume":"60","author":"Baldwin","year":"2000","journal-title":"Cancer Res"},{"key":"2022060816275180400_bib27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2644","article-title":"The biology of ovarian cancer: new opportunities for translation","volume":"9","author":"Bast","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"2022060816275180400_bib28","doi-asserted-by":"crossref","first-page":"x16","DOI":"10.1093\/annonc\/mdt463","article-title":"Origin and molecular pathogenesis of ovarian high-grade serous carcinoma","volume":"24","author":"Kurman","year":"2013","journal-title":"Ann Oncol"},{"key":"2022060816275180400_bib29","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/IGC.0b013e31821bc7e3","article-title":"Risk-Reducing Salpingo-Oophorectomy (RRSO) in BRCA mutation carriers experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol","volume":"21","author":"Powell","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"2022060816275180400_bib30","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer\u2013shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum Pathol"},{"key":"2022060816275180400_bib31","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J Clin Oncol"},{"key":"2022060816275180400_bib32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1158\/1940-6207.CAPR-10-0266","article-title":"Microscopic and early-stage ovarian cancers in BRCA1\/2 mutation carriers: building a model for early BRCA-associated tumorigenesis","volume":"4","author":"Yates","year":"2011","journal-title":"Cancer Prev Res"},{"key":"2022060816275180400_bib33","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/IGC.0b013e31824d7269","article-title":"BRCA, the oviduct, and the space and time continuum of pelvic serous carcinogenesis","volume":"22","author":"Crum","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"2022060816275180400_bib34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"2022060816275180400_bib35","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol Oncol"},{"key":"2022060816275180400_bib36","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"2022060816275180400_bib37","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/onc.2009.402","article-title":"Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis","volume":"29","author":"Levanon","year":"2010","journal-title":"Oncogene"},{"key":"2022060816275180400_bib38","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"key":"2022060816275180400_bib39","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","article-title":"Ovarian conservation at the time of hysterectomy and long-term health outcomes in the Nurses' Health Study","volume":"113","author":"Parker","year":"2009","journal-title":"Obstet Gynecol"},{"key":"2022060816275180400_bib40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12609-009-0022-4","article-title":"Prophylactic oophorectomy may differentially reduce breast cancer risk in women with BRCA1 versus BRCA2 mutations","volume":"1","author":"Arnold","year":"2009","journal-title":"Curr Breast Cancer Rep"},{"key":"2022060816275180400_bib41","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10549-009-0475-1","article-title":"Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence","volume":"118","author":"Shah","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"2022060816275180400_bib42","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2217\/WHE.09.42","article-title":"Effect of bilateral oophorectomy on women's long-term health","volume":"5","author":"Parker","year":"2009","journal-title":"Women's Health"},{"key":"2022060816275180400_bib43","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1470-2045(06)70869-5","article-title":"Survival patterns after oophorectomy in premenopausal women: a population-based cohort study","volume":"7","author":"Rocca","year":"2006","journal-title":"Lancet Oncol"},{"key":"2022060816275180400_bib44","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1200\/JCO.2005.02.626","article-title":"Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer","volume":"23","author":"Madalinska","year":"2005","journal-title":"J Clin Oncol"},{"key":"2022060816275180400_bib45","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0090-8258(03)00072-6","article-title":"Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy","volume":"89","author":"Robson","year":"2003","journal-title":"Gynecol Oncol"},{"key":"2022060816275180400_bib46","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.fertnstert.2003.11.036","article-title":"Influence of the Women's Health Initiative trial on the practice of prophylactic oophorectomy and the prescription of estrogen therapy","volume":"81","author":"Chan","year":"2004","journal-title":"Fertil Steril"},{"key":"2022060816275180400_bib47","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","article-title":"Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group","volume":"23","author":"Rebbeck","year":"2005","journal-title":"J Clin Oncol"},{"key":"2022060816275180400_bib48","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1210\/jc.2007-0581","article-title":"Ovarian androgen production in postmenopausal women","volume":"92","author":"Fogle","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2022060816275180400_bib49","first-page":"645","article-title":"Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study","volume":"85","author":"Laughlin","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2022060816275180400_bib50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/humupd\/dmp037","article-title":"Should the ovaries be removed or retained at the time of hysterectomy for benign disease?","volume":"16","author":"Hickey","year":"2010","journal-title":"Hum Reprod Update"},{"key":"2022060816275180400_bib51","first-page":"37","article-title":"Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women","volume":"81","author":"Raisz","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2022060816275180400_bib52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2007-1016262","article-title":"Cardiovascular aspects of androgens in women. Seminars in reproductive endocrinology","volume":"16","author":"Sarrel","year":"1998","journal-title":"Semin Reprod Endocrinol"},{"key":"2022060816275180400_bib53","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.gme.0000218683.97338.ea","article-title":"Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis","volume":"13","author":"Atsma","year":"2006","journal-title":"Menopause"},{"key":"2022060816275180400_bib54","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/gme.0b013e31803c56a4","article-title":"Elective oophorectomy for benign gynecological disorders","volume":"14","author":"Shoupe","year":"2007","journal-title":"Menopause"},{"key":"2022060816275180400_bib55","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/archinternmed.2011.121","article-title":"Oophorectomy vs ovarian conservation with hysterectomy cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study","volume":"171","author":"Jacoby","year":"2011","journal-title":"Arch Intern Med"},{"key":"2022060816275180400_bib56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1385\/ENDO:24:3:195","article-title":"Is the WHI relevant to HRT started in the perimenopause?","volume":"24","author":"Harman","year":"2004","journal-title":"Endocrine"},{"key":"2022060816275180400_bib57","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ygyno.2011.02.012","article-title":"Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development","volume":"121","author":"Leblanc","year":"2011","journal-title":"Gynecol Oncol"},{"key":"2022060816275180400_bib58","first-page":"113","article-title":"Ovarian cancer in women with prior hysterectomy","volume":"155","author":"Davis","year":"2003","journal-title":"J La State Med Soc"},{"key":"2022060816275180400_bib59","first-page":"386","article-title":"Ovarian cancer after hysterectomy","volume":"69","author":"McGowan","year":"1987","journal-title":"Obstet Gynecol"},{"key":"2022060816275180400_bib60","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.fertnstert.2014.03.041","article-title":"Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies","volume":"102","author":"Rice","year":"2014","journal-title":"Fertil Steril"},{"key":"2022060816275180400_bib61","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jmig.2012.11.010","article-title":"Surgical implications of the potential new tubal pathway for ovarian carcinogenesis","volume":"20","author":"Chene","year":"2013","journal-title":"J Minim Invas Gyn"},{"key":"2022060816275180400_bib62","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ajog.2014.01.003","article-title":"Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention","volume":"210","author":"McAlpine","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"2022060816275180400_bib63","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ajog.2013.05.015","article-title":"Risk-reducing salpingectomy as a new and safe strategy to prevent ovarian cancer","volume":"209","author":"Morelli","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"2022060816275180400_bib64","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.fertnstert.2013.07.1997","article-title":"Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial","volume":"100","author":"Findley","year":"2013","journal-title":"Fertil Steril"},{"key":"2022060816275180400_bib65","doi-asserted-by":"crossref","first-page":"126S","DOI":"10.1097\/01.AOG.0000447088.95480.bc","article-title":"Salpingectomy at the time of hysterectomy for benign indications: a survey study","volume":"123","author":"Morosky","year":"2014","journal-title":"Obstet Gynecol"},{"key":"2022060816275180400_bib66","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jmig.2013.02.010","article-title":"Physician opinions regarding elective bilateral salpingectomy with hysterectomy and for sterilization","volume":"20","author":"Gill","year":"2013","journal-title":"J Minim Invasive Gynecol"},{"key":"2022060816275180400_bib67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-pathol-020712-163949","article-title":"Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma","volume":"9","author":"Nik","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"2022060816275180400_bib68","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ygyno.2013.01.029","article-title":"Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy","volume":"129","author":"Powell","year":"2013","journal-title":"Gynecol Oncol"},{"key":"2022060816275180400_bib69","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","article-title":"Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study","volume":"23","author":"Eisen","year":"2005","journal-title":"J Clin Oncol"},{"key":"2022060816275180400_bib70","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1158\/1055-9965.EPI-12-0201","article-title":"Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"21","author":"Kotsopoulos","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060816275180400_bib71","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1111\/j.1524-4741.2004.101S3.x","article-title":"Efficacy of risk-reducing salpingo-oophorectomy in women with BRCA-1 and BRCA-2 mutations","volume":"10","author":"Olopade","year":"2004","journal-title":"Breast J"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/8\/5\/342\/2336853\/342.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/8\/5\/342\/2336853\/342.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T18:41:16Z","timestamp":1654713676000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/8\/5\/342\/50396\/Salpingectomy-as-a-Means-to-Reduce-Ovarian-Cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,30]]},"references-count":71,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,4,30]]},"published-print":{"date-parts":[[2015,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-14-0293","relation":{},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,30]]}}}